We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

116 hedge funds and large institutions have $51.1M invested in Ventyx Biosciences in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 39 increasing their positions, 34 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 34

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 124 → 116 (-8)

14.59% less ownership

Funds ownership: 77% → 62.42% (-15%)

35% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 23

36% less call options, than puts

Call options by funds: $39K | Put options by funds: $61K

57% less capital invested

Capital invested by funds: $119M → $51.1M (-$68.2M)

Holders
116
Holders Change
-8
Holders Change %
-6.45%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
15
Increased
39
Reduced
34
Closed
23
Calls
$39K
Puts
$61K
Net Calls
-$22K
Net Calls Change
+$154K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.21M
2
RG
Redmile Group
California
+$2.48M
3
MAM
Monaco Asset Management
Monaco
+$1.54M
4
AQR Capital Management
AQR Capital Management
Connecticut
+$1.36M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$753K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$5.96M
2
Bank of America
Bank of America
North Carolina
-$5.59M
3
Citadel Advisors
Citadel Advisors
Florida
-$5.3M
4
Morgan Stanley
Morgan Stanley
New York
-$2.81M
5
SCM
Sio Capital Management
New York
-$2.51M
Name Holding Trade Value Shares
Change 		Change in
Stake
QUSVM
26
Qiming U.S. Ventures Management
Washington
$474K – – –
BFM
27
Boothbay Fund Management
New York
$406K +$65.2K +37,974 +12%
TCM
28
TCG Crossover Management
California
$364K – – –
UBS Group
29
UBS Group
Switzerland
$356K -$5.96M -3,472,971 -92%
ACM
30
ADAR1 Capital Management
Texas
$324K +$270K +157,070 +126%
WC
31
Wexford Capital
Florida
$321K -$205K -119,232 -30%
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$314K +$206K +120,121 +79%
CIBC World Market
33
CIBC World Market
Ontario, Canada
$313K +$352K +205,000 +304%
SC
34
Shay Capital
New York
$301K +$235K +136,909 +110%
Millennium Management
35
Millennium Management
New York
$260K -$1.81M -1,055,319 -82%
GCM
36
Graham Capital Management
Connecticut
$250K +$374K +217,646 New
WP
37
Woodline Partners
California
$240K -$7.87K -4,584 -2%
Two Sigma Advisers
38
Two Sigma Advisers
New York
$226K -$1.04M -604,271 -75%
IC
39
IEQ Capital
California
$223K +$333K +194,189 New
Dimensional Fund Advisors
40
Dimensional Fund Advisors
Texas
$221K +$57.6K +33,552 +21%
OM
41
Opaleye Management
Massachusetts
$219K -$155K -90,000 -32%
SFI
42
Susquehanna Fundamental Investments
Pennsylvania
$209K -$29.4K -17,098 -9%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$201K -$3.16K -1,841 -1%
N
44
Nuveen
North Carolina
$194K – – –
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$155K +$14.5K +8,467 +7%
HighTower Advisors
46
HighTower Advisors
Illinois
$142K +$32.6K +18,985 +18%
Invesco
47
Invesco
Georgia
$135K -$49K -28,562 -20%
AllianceBernstein
48
AllianceBernstein
Tennessee
$117K – – –
BCM
49
Bridgeway Capital Management
Texas
$113K -$184K -106,900 -52%
T. Rowe Price Associates
50
T. Rowe Price Associates
Maryland
$111K +$93.4K +54,400 +132%
1
2
3 4 5

VTYX Hedge Fund Activity: Q1 2025 in Review

116 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q1 2025, worth a combined $51.1M — down 57% from $119M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of VTYX and 15 opened new positions — a net loss of 8 holders — while 34 trimmed existing stakes and 39 added.

The largest buyer was Point72 Asset Management, adding an estimated $4.21M. The largest seller was UBS Group, cutting an estimated $5.96M.

  • 116 institutional investors held Ventyx Biosciences (VTYX) as of Q1 2025, down from 124 in Q4 2024.
  • Funds reported $51.1M of Ventyx Biosciences stock for Q1 2025, down 57% quarter-over-quarter.
  • 15 funds opened new Ventyx Biosciences positions in Q1 2025 and 23 closed out, a net change of -8 holders.
  • The largest Ventyx Biosciences buyer in Q1 2025 was Point72 Asset Management, an estimated $4.21M added.
  • The largest Ventyx Biosciences seller in Q1 2025 was UBS Group, an estimated $5.96M sold.

Based on aggregated 13F filings for Q1 2025.